Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Potential Late Side Effects of Semaglutide

Common Late Side Effects

  • Nausea, vomiting, diarrhea, and esophageal reflux are the most common side effects, which may persist for some time after discontinuation of semaglutide, as reported by the American Diabetes Association 1, 2
  • Severe constipation and small bowel obstruction/ileus progression can occur and may develop even after stopping the medication, according to the American Diabetes Association 1, 3
  • Gastrointestinal side effects are dose-dependent and more frequent with short-acting formulations, as noted by the American Society of Anesthesiologists 4, 5

Serious Late Side Effects

  • Pancreatitis has been reported in clinical trials, though causality has not been definitively established, as reported by the American Diabetes Association 1, 3
  • Acute kidney injury risk may persist, particularly in patients with pre-existing kidney disease, according to the American Diabetes Association 1, 3
  • Elevated heart rate may persist after discontinuation of semaglutide, as noted by the American Heart Association 1, 4
  • Cardiac arrhythmias may occur and should be monitored, particularly in patients with pre-existing cardiovascular conditions, as recommended by the American Heart Association 4, 5

Medication Interactions and Absorption Issues

  • Delayed absorption of oral medications may persist temporarily after discontinuation of semaglutide, as reported by the American Diabetes Association 1, 3
  • Particular attention should be paid to medications with narrow therapeutic indices (e.g., warfarin), according to the American Diabetes Association 3
  • Hormonal contraception efficacy may be affected for up to 4 weeks after dose changes of semaglutide, as noted by the American Diabetes Association 3

Monitoring Recommendations After Discontinuation

  • Monitor for persistent gastrointestinal symptoms for several weeks after discontinuation of semaglutide, as recommended by the American Society of Anesthesiologists 4, 5
  • Be alert for signs of gallbladder disease (right upper quadrant pain, nausea) after discontinuation of semaglutide, according to the Obesity Society 2, 6
  • For patients with diabetes, monitor glycemic control closely as rebound hyperglycemia may occur after discontinuation of semaglutide, as recommended by the American Diabetes Association 1, 8

Special Considerations

  • Patients with a history of pancreatitis require extra vigilance even after discontinuation of semaglutide, as recommended by the American College of Cardiology 9
  • Patients with kidney disease need continued monitoring of renal function after discontinuation of semaglutide, according to the American Diabetes Association 1